Deciphera Pharmaceuticals, Inc. (DCPH)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 11:28AM EDT. Market open.
| Previous Close | 13.73 |
| Open | 13.79 |
| Bid | 13.72 x 1000 |
| Ask | 13.76 x 800 |
| Day's Range | 13.41 - 13.95 |
| 52 Week Range | 6.51 - 37.99 |
| Volume | |
| Avg. Volume | 1,253,130 |
| Market Cap | 897.234M |
| Beta (5Y Monthly) | 1.40 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Deciphera (DCPH) Up More Than 30% in Past 3 Months: Here's Why
Deciphera's (DCPH) Qinlock, approved for treating advanced gastrointestinal stromal tumors, has seen strong uptake since its approval. The recent restructuring initiative is saving costs.
- Zacks
Deciphera Pharmaceuticals, Inc. (DCPH) Up 4.3% Since Last Earnings Report: Can It Continue?
Deciphera Pharmaceuticals, Inc. (DCPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Simply Wall St.
We Think Deciphera Pharmaceuticals (NASDAQ:DCPH) Needs To Drive Business Growth Carefully
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
© 2022 Yahoo. All rights reserved.
